The Race to Innovate: Balancing AI Opportunity and Risk in Life Sciences
For life sciences companies under pressure to move quickly, AI offers new ways to accelerate progress. It also raises practical questions about governance, data stewardship,...
For life sciences companies under pressure to move quickly, AI offers new ways to accelerate progress. It also raises practical questions about governance, data stewardship,...
In the life sciences, the work of raising capital often receives the most attention. Yet the months that follow can shape how effectively that capital...
The tax landscape continues to evolve, creating both opportunities and planning considerations for life sciences companies at every stage of growth.
Grant funding can accelerate innovation and extend runway for life sciences companies. It also introduces new operational, financial, and compliance demands that shape how your...
To secure funding in today’s market, life sciences companies need to show how their financial, operational, and strategic plans work together in practice.
Interest is rising in life‑science pipelines, and companies that succeed combine strong science with disciplined financial and operational foundations.
If you’re expanding into the U.S., early decisions around IP, intercompany agreements, and documentation can create risk—or set you up for smoother fundraising, tax savings,...
SOC reports are often discussed as if they are interchangeable. In practice, that assumption breaks down quickly. A SOC 1 report is not a general...
Strong internal controls under SOX 404(a) help organizations prevent errors, improve operational consistency, and maintain confidence with stakeholders. Effective compliance turns regulatory requirements into a...